- Home
- Free App Analytics
- Eczema CARE+
- Eczema CARE+ Vs. SKINDRUG by Dermaweb
Eczema CARE+ vs SKINDRUG by Dermaweb Usage & Stats
ECZEMA CARE+ is the free application that helps you live better with your eczema!
Designed and developed by the Pierre Fabre Eczema Foundation, it allows you to:
- Assess the severity of your eczema by calculating your PO-SCORAD index or using photos and artificial intelligence.
- Follow the evolution of your disease thanks to a dashboard.
- Prepare your medical appointment in advance with questionnaires
- Share this information directly with your healthcare professionals in a secure manner to receive personalized advice
- Follow up on your consultation
- Access tips and tools to help you live better with your eczema.
The information provided by the app cannot be used to provide a medical opinion, or to replace a visit to a healthcare professional.
The information provided by the app is intended to enhance - not replace - the relationship that exists between a patient and his/her caregivers.
- Apple App Store
- Free
- Medical
Store Rank
- -
A toxidermia database in your pocket !
- Find out about skin reactions attributable to a drug, thanks to direct access to the toxidermia database on our website www.dermaweb.com.
- 2328 INNs (International Non-proprietary Names), associated with 744 pathologies and nearly 716 therapeutic families,
- Search by INN or pathology,
- Daily use in offline mode after download,
- Access strictly reserved for healthcare professionals and Dermaweb members,
- Regular database updates.
- Apple App Store
- Free
- Medical
Store Rank
- -
Eczema CARE+ vs. SKINDRUG by Dermaweb ranking comparison
Compare Eczema CARE+ ranking trend in the past 28 days vs. SKINDRUG by Dermaweb
Rank
No Data Available
Eczema CARE+ vs. SKINDRUG by Dermaweb ranking by country comparison
Compare Eczema CARE+ ranking trend in the past 28 days vs. SKINDRUG by Dermaweb
All categories
No Data Available
Medical
Compare to any site with our free trial
Eczema CARE+ VS.
SKINDRUG by Dermaweb
January 3, 2025